Dare Bioscience, Inc.
DARE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001401914
No open-market purchases or sales by Dare Bioscience, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $2.75M in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Dare Bioscience, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Of which not filed for Q4 2024 | Q4 2024 | Change |
|---|---|---|---|---|
| Holders | 22 | 1 | 25 | +4 |
| Shares | 655.4K | 9 | 777.2K | +121.9K (+18.6%) |
| Value | $2.08M | $30 | $2.43M | +$345.5K (+16.6%) |
1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (7)
Institutions that held Dare Bioscience, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 40,582 | $126.6K | 0.00% |
| Jane Street Group, LLC | 16,584 | $51.7K | 0.00% |
| Allworth Financial LP | 1,667 | $5.47K | 0.00% |
| SBI Securities Co., Ltd. | 575 | $1.79K | 0.00% |
| Advisor Group Holdings, Inc. | 25 | $78 | 0.00% |
| Morgan Stanley | 7 | $22 | 0.00% |
| Putney Financial Group LLC | 1 | $3 | 0.00% |
Sold out (3)
Institutions that held Dare Bioscience, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Founders Financial Securities LLC | 11,586 | $37.5K |
| Advisory Services Network, LLC | 15,000 | $5.04K |
| Bryn Mawr Trust Co | 71 | $230 |
Not filed for Q4 2024 yet (1)
Institutions that held Dare Bioscience, Inc. at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Planning Capital Management Corp | 9 | $30 |